ArticleCancers2021

An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary Glioblastoma.

Colin Watts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.